Rho Celebrates 25th Anniversary
Chapel Hill, NC
October 24, 2009 marked the 25th Anniversary for Rho, a Chapel Hill based contract research organization. Established in 1984, Rho began as a small, family run business in the basement of the home of Ron and Mary Helms. Since then, it has rapidly developed into a large family owned company that conducts business with some of the most dynamic pharmaceutical, biotech, and medical device companies in the U.S.
During the past 25 years, Rho has acquired a strong commercial and federal customer base because of its customer service and scientific expertise. Consulting to the FDA, rescuing poorly executed pivotal trials, authoring and coauthoring 252 articles, 89 presentations, and 82 abstracts are
among of Rho’s accomplishments.
Rho contributes to the success of pharmaceutical, medical device, and biotechnology studies in a range of therapeutic areas.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
